Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Radiology and Oncology
Volume 56 (2022): Issue 2 (June 2022)
Open Access
Cervix-Online computer program: 27 years of hospital-based clinical registry for cervical cancer at the University Medical Centre Maribor
Vida Gavric Lovrec
Vida Gavric Lovrec
,
Darja Arko
Darja Arko
and
Iztok Takac
Iztok Takac
| Dec 22, 2021
Radiology and Oncology
Volume 56 (2022): Issue 2 (June 2022)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Research Article
Published Online:
Dec 22, 2021
Page range:
198 - 207
Received:
Sep 13, 2021
Accepted:
Nov 22, 2021
DOI:
https://doi.org/10.2478/raon-2021-0054
© 2022 Vida Gavric Lovrec, Darja Arko, Iztok Takac, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1
General data. CT = chemotherapy; RT = radiotherapy
Figure 2
Medical history, clinical examination, clinical stage (preoperative International Federation of Gynecology and Obstetrics [FIGO] stage). AGC - neoplastic = atypical glandular cells - neoplastic; AGC-NOS = atypical glandular cells - not otherwise specified; AIS = adenocarcinoma in situ; AC = adenocarcinoma; ASC-US = atypical squamous cells - of undetermined significance; ASC-H = atypical squamous cells - cannot exclude HSIL; GIT = gastrointestinal tract; HGSIL = high grade squamous intraepithelial lesion; IUD = intrauterine device; IUS = intrauterine system; LGSIL = low grade squamous intraepithelial lesion; MLG-N = other malignant cells - inevaluable; MTOP = medical termination of pregnancy; N/A = not available; SCC = squamous cell carcinoma; SFM-NOS = suspicious for malignancy - not otherwise specified
Figure 3
Tests at initial examination. CEA = carcinoembryonic antigen; L = left; NAD = no evidence of disease; R = right; SCC = squamous cell carcinoma antigen
Figure 4
Treatment. CT = chemotherapy: DVT = deep vein thrombosis; G-CSF = granulocyte colony stimulating factor
Figure 5
Histopathology, International Federation of Gynecology and Obstetrics (FIGO) stage after definitive histology. L = left; R = right
Figure 6
Chemotherapy cycles. CEA = carcinoembryonic antigen; G-CSF = granulocyte colony stimulating factor; NAD = nothing abnormal detected; SCC = squamous cell carcinoma antigen
Figure 7
Follow-up form. TH = therapy; NAD = nothing abnormal detected; ASC-US = atypical squamous cells of undetermined significance; ASC-H = atypical squamous cells – cannot exclude HSIL; LGSIL = low-grade squamous intraepithelial lesion ; HGSIL = high grade squamous intraepithelial lesion; SCC = squamous cell carcinoma; AGC-NOS = atypical glandular cells not otherwise specified; AGC-neoplastic = atypical glandular cells, suspicious for AIS or cancer; AIS = adenocarcinoma in situ; AC = adenocarcinoma; SFM-NOS = suspicious for malignancy; MLG-N = malignancy; SCC = squamous cell carcinoma antigen; CEA = carcinoembryonic antigen; UTI = urinary tract infection
Preview